• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Fresh2 Group Limited

    12/23/24 4:02:53 PM ET
    $FRES
    Medical Specialities
    Health Care
    Get the next $FRES alert in real time by email
    6-K 1 ea0225827-6k_fresh2.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    U.S. SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of December 2024

     

    Commission File Number: 001-39137

     

    Fresh2 Group Limited

     

    880 3RD AVE FL 7

    NEW YORK, NY 10022-4730

    United States

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F  ☒     Form 40-F  ☐

     

     

     

     

    EXPLANATORY NOTE

     

    On December 20, 2024, Fresh2 Group Limited (the Company) received notification from The Nasdaq Stock Market (Nasdaq) stating that the Company’s securities will be delisted from the Nasdaq Capital Market effective at the open of the market on December 24, 2024. The delisting of the Company’s securities is a result of the Company’s failure to regain compliance with the the Periodic Filing Rule for continued listing, pursuant to Nasdaq’s Listing Rule 5250(c)(1).

     

    The Company received a Staff Determination Letter from the Nasdaq on October 16, 2024, indicating that the Company did not comply with Nasdaq’s filing requirements as set forth in Listing Rule 5250(c)(1). On October 23, 2024, the Company requested a hearing before a Nasdaq Hearings Panel to appeal the delisting determination. The hearing was held on December 16, 2024. In the Hearing, the company presented company overview and compliance plan to request an exception through April 14, 2025, to file the Delayed Reports. The Nasdaq Hearings Panel (“Panel”) has determined to deny the request. As a result, trading in the Company’s securities at Nasdaq will be suspended at the open of trading on December 24, 2024.

     

    The Company expects its securities to trade on the Pink Market.

     

    The Company is committed to filing the delayed reports to demonstrate full compliance with its filing requirements. It has been allocating all necessary and appropriate resources to complete the audit and submit the delayed reports. Once compliance is restored, the Company intends to apply for an uplisting.

     

    1

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 23, 2024 Fresh2 Group Limited
       
      By: /s/ Haohan Xu
      Name:  Haohan Xu
      Title: Chief Executive Officer

     

     

    2

     

     

    Get the next $FRES alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FRES
    SEC Filings

    View All

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    12/23/24 4:02:53 PM ET
    $FRES
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    11/14/24 4:15:32 PM ET
    $FRES
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    7/24/24 4:01:19 PM ET
    $FRES
    Medical Specialities
    Health Care

    $FRES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing

    New York, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or the "Company"), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on October 16, 2024, it received a Staff Determination Letter from the Nasdaq Stock Market LLC ("Nasdaq")  indicating that the Company did not comply with Nasdaq's filing requirements as set forth in Listing Rule 5250(c)(1). The letter is a result of the Company's failure to file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, and June 30, 2024, within the required deadlines. Nasdaq had previously granted

    10/17/24 4:05:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq

    New York, NY, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or the "Company"), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on August 19 , 2024, it received an additional delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising they have not received the Company's Form 10-Q for the period ended June 30, 2024, it does not comply with the Listing Rules 5250(c)(1) (the "Rules"), which requires the timely filing of all required periodic reports with the SEC. Previously, Nasdaq Staff had granted the Company an exception

    8/22/24 4:05:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Announces Collaboration with Over 50 Influencers in Video E-commerce

    New York, NY, July 16, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that its video e-commerce business has partnered with over 50 influencers, resulting in continued rapid sales growth. By leveraging these key partnerships, Fresh2's video e-commerce business is rapidly expanding its market presence in the e-commerce sector. (Screenshot of some Company's venues at tiktok) The Power of Video E-commerce Unlike traditional e-commerce, video e-commerce uses multimedia formats, which offer stronger visual appeal and can hi

    7/16/24 9:15:00 AM ET
    $FRES
    Medical Specialities
    Health Care

    $FRES
    Leadership Updates

    Live Leadership Updates

    View All

    Appointment of New Independent Director

    NEW YORK, Dec. 15, 2023 /PRNewswire/ -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced the appointment of Zhijun (Michael) Liang, as an independent director of the Company, effective January 1, 2024. Zhijun (Michael) Liang, has spent more than two decades providing management consulting and investment management services, primarily to start-ups and growth businesses, enabling them to address expansion needs and financial challenges. He co-founded Beijing Yuantong Funds Management Co., Ltd., and has led its risk and investment management since 2018. Concurrently, as the

    12/15/23 4:01:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Group Ltd. Appoints New Chief Strategy Officer to Drive Advancement and Execution of Long-Term Growth Strategy

    NEW YORK, July 26, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ:FRES) ("Fresh2," the "Company" or "we"), a company with operations in the United States and China focused on the business-to-business e-commerce and supply chain sectors for the restaurant supply and food industry and on early cancer screening and detection,  today announced the appointment of Mr. Yidong Hu as its Chief Strategy Officer (CSO) effective on July 21, 2023. Mr. Hu was appointed to drive the advancement and execution of the Company's long-term strategy. Mr. Hu is a seasoned executive with over a decade of experience in the media and finance sectors. Mr.Hu has served as

    7/26/23 9:00:00 AM ET
    $FRES
    Medical Specialities
    Health Care